Mirae Asset Global ETFs Holdings
AMPH icon

Mirae Asset Global ETFs Holdings’s Amphastar Pharmaceuticals AMPH Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Sell
14,873
-1,973
-12% -$39.8K ﹤0.01% 2286
2026
Q1 		$330K Sell
16,846
-33
-0.2% -$807 ﹤0.01% 2100
2025
Q4 		$452K Sell
16,879
-363
-2% -$9.35K ﹤0.01% 1943
2025
Q3 		$459K Sell
17,242
-3,096
-15% -$79.9K ﹤0.01% 1903
2025
Q2 		$467K Sell
20,338
-2,151
-10% -$53.4K ﹤0.01% 1853
2025
Q1 		$652K Buy
22,489
+613
+3% +$19.6K ﹤0.01% 1725
2024
Q4 		$812K Buy
21,876
+792
+4% +$36.2K ﹤0.01% 1660
2024
Q3 		$1.02M Buy
21,084
+1,560
+8% +$68.5K ﹤0.01% 1531
2024
Q2 		$781K Buy
+19,524
New +$809K ﹤0.01% 1593

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mirae Asset Global ETFs Holdings's AMPH Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Amphastar Pharmaceuticals (AMPH) stake by 12% in Q2 2026, selling an estimated $39.8K and leaving 14,873 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

Mirae Asset Global ETFs Holdings first reported a position in AMPH in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.02M in Q3 2024. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 14,873 shares of Amphastar Pharmaceuticals worth $300K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 1,973 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $39.8K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2286 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Amphastar Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Amphastar Pharmaceuticals position peaked at $1.02M in Q3 2024.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.